HIF1A and cancer: Under these conditions the growth advantage of cancer cells over nonmalignant cells depends on cancer cell adaptation to glycolysis and is driven by the transcription factor hypoxia-inducible factor 1α (HIF1α) which is stabilized by hypoxia (37).